Annual Drug Patent Expirations for INVEGA+HAFYERA
Invega Hafyera is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.
This drug has six patent family members in three countries.
The generic ingredient in INVEGA HAFYERA is paliperidone palmitate. One supplier is listed for this compound. Additional details are available on the paliperidone palmitate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
